| 摘要 |
The invention concerns bis-anthracene compounds isolated from Karwinskia humboldtiana and used in therapy. The compounds of the invention are selective with a high margin of safety relative to malignant tumor cells and therefore are suitable in particular in the treatment of liver, lung and colon carcinomas and further in the treatment of viral diseases. In particular, the invention is for a pharmaceutical composition which contains a compound selected from compounds of formulae I through VI:
|
